Science on Screen: See "Steel Magnolias" followed by Q&A with Dr. Eva Feldman at Ann Arbor's Michigan Theater
Twenty-five years after “Steel Magnolias”: Dr. Eva Feldman shares the latest in treatment of diabetes complications at the Michigan Theater’s April 16 session of Science on Screen
Twenty-five years ago, when millions of movie-goers laughed and then cried over the saga of M’Lynn, her diabetic daughter Shelby and their eccentric friends and relatives in “Steel Magnolias,” about 6.3 million Americans were living with diabetes.
Today, nearly 26 million Americans have diabetes -- and if unchecked, the rising incidence of the disease will affect one in every three Americans by 2050, according to the American Diabetes Association. The cost of diabetes is estimated at more than $250 billion a year in the United States alone and the non-monetary cost to quality of life for patients and their families is immeasurable.
Diabetes has adverse effects on the entire body, from heart to kidneys to eyes. And the neurological complications of diabetes can be particularly debilitating. As many as 70 percent of diabetics suffer some form of nervous system damage, leading to pain, loss of sensation and loss of mobility. Currently, no effective treatment exists for this nerve damage.
But there is hope.
Dr. Eva Feldman, the Russell N. DeJong Professor of Neurology at the University of Michigan Medical School and the director of the A. Alfred Taubman Medical Research Institute, is a practicing neurologist whose research laboratory seeks new discoveries about the cause and treatment of diabetic neuropathy and other complications.
Her laboratory, the Program for Neurology Research & Discovery, is attacking this huge health problem in many ways. PNR&D scientists are discovering how high blood sugar injures nerves, why this causes pain, and how over time diabetes destroys the nerves. By simulating the insults that nerve cells undergo with diabetes in cultured cells, and studying neuronal changes in patients with diabetic neuropathy, Dr. Feldman and her staff has discovered some of the key mechanistic pathways involved in neuronal injury during diabetes. These pathways have become the subjects for development of new, groundbreaking therapies.
Join Dr. Feldman for the April 16 installment of Science on Screen, the innovative series at Ann Arbor's historic Michigan Theater that pairs films with expert guest speakers for the perfect combination of entertainment and enlightenment. Following the 7 p.m. showing of “Steel Magnolias,” Dr. Feldman will share the latest developments in treatment and take questions from audience members.
Visit the Michigan Theater website for additional information.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.